NEUVIOR®
UK Pharma Infrastructure, AI & Medicines OS
NEUVIOR is a UK pharmaceutical group building infrastructure across medicines intelligence, resilient supply, applied research and pharmacy operations. PHARMORIS® is the flagship operating system at the centre of that strategy.
Our Accreditations & Partners
Proof Points & Recent Milestones
Early validation for the NEUVIOR® platform across innovation, governance, IP and lower-waste pharmaceutical manufacturing research.
Innovate UK Growth Catalyst – New Innovators Award
Awarded for PHARMORIS - Generics Optimisation Platform for NHS and Global Health.
Innovate UK - Resource efficiency for resilience and sustainability Award
Awarded for ZYLON: Bio-intelligent Materials for Net-Zero Pharmaceutical Manufacturing
NHS Evergreen Level 2 Achieved
Confirmed at Level 2 under the NHS Evergreen Sustainable Supplier Assessment, strengthening our sustainability and supplier-readiness profile.
PHARMORIS®
The Governed Medicines Action Layer.
What PHARMORIS does
Discover
Continuously ingests data from dm+d, NHSBSA, patent expiries and other relevant sources to identify and rank the highest-value supply-risk opportunities.
Justify
These opportunities are then turned into clear, evidence-based cases, showing why they matter and how confident we are in each one.
Deploy
We then create the action plan for implementation, including ownership, timelines and how value will be realised.
Data & Assurance
Keeps outputs current, transparent, auditable and accessible to the right people, with governance built in from the start.
Benefits across the medicines ecosystem
For Patients
- Better continuity of access to appropriate medicines
- Fewer avoidable disruptions from shortages or switching
- More consistent care pathways across settings
- Lower-cost delivery without compromising quality or safety
For Healthcare Providers
- Prioritised action portfolios instead of dashboard overload
- Board-ready evidence for pharmacy, finance and executive teams
- Clear deployment plans with owners and milestones
- Stronger response to leakage, concessions and supply stress
For Health Systems
- Faster medicines value capture
- Reduced unwarranted variation and avoidable spend
- Improved supply resilience and governance visibility
- A clearer bridge from insight to operational execution
PHARMORIS® workflow
A medicines value workflow designed around Discover, Justify and Deploy rather than another passive dashboard.
Discover
Ingests medicines, pricing, shortage and product-identity data to surface the highest-value opportunities first.
Justify
Turns shortlisted opportunities into decision-grade evidence packs with rationale, confidence and source provenance.
Deploy
Models implementation across ICBs, trusts, providers and pharmacy teams with clear owners, sequencing and value assumptions.
Review & Report
Tracks realised value, unresolved blockers, data freshness and portfolio progress through recurring review cycles.
ZYLON™
Applied manufacturing R&D exploring bio-intelligent materials and solvent recovery pathways for lower-waste pharmaceutical production.
Why ZYLON matters
Environmental Pathways
- Explores lower-waste and lower-emission manufacturing routes
- Examines solvent recovery opportunities in pharmaceutical production
- Builds around circular-design principles rather than one-off sustainability claims
- Creates a research base for future industrial partnerships
Process Assurance
- Feasibility work is framed for regulated manufacturing environments
- Quality, safety and reproducibility remain non-negotiable
- Uses data-led process analysis rather than speculative positioning
- Focuses on manufacturing reality as well as innovation potential
Strategic Value
- Extends NEUVIOR beyond software into broader pharmaceutical infrastructure
- Creates a sustainability and resilience narrative that investors can underwrite
- Supports future partnerships across manufacturing and materials science
- Shows long-term optionality beyond the initial PHARMORIS wedge
ZYLON™ development flow
A staged pathway from manufacturing problem selection to feasibility outputs and partnership-ready scale decisions.
Feasibility Mapping
Define target waste streams, bottlenecks and decarbonisation opportunities inside real pharmaceutical manufacturing contexts.
Process Intelligence
Apply AI-led analysis to solvent recovery, process efficiency and operational trade-offs.
Material Prototyping
Evaluate bio-intelligent materials and packaging concepts compatible with pharmaceutical quality expectations.
Industrial Pathway
Translate feasibility outputs into pilot opportunities, partner conversations and future scale-up decisions.
Assurance, governance & operating readiness
Start the conversation
NEUVIOR engages with health systems, investors, journalists, strategic partners and governance stakeholders who want infrastructure-grade thinking in medicines.
Book a PHARMORIS® demo
Request a product walkthrough for ICBs, NHS trusts, provider collaboratives, pharmacy leaders or strategic partners.
Investors & partnerships
Discuss the group model, protected product architecture, strategic capital and long-term infrastructure roadmap.
Media & policy briefings
Request founder commentary, background briefings or approved materials for coverage, diligence and stakeholder discussions.
Platform Updates
Subscribe to receive product releases, feature updates, and innovation insights